RecruitingPhase 2NCT07570862
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
Sponsor: Fate Therapeutics
Beverly Hills, CA · Fontana, CA · Fullerton, CA · +9 more sites
2 recruiting lupus studies with a site in Irvine, CA.
Sponsor: Fate Therapeutics
Beverly Hills, CA · Fontana, CA · Fullerton, CA · +9 more sites
Sponsor: Fate Therapeutics
Beverly Hills, CA · Fullerton, CA · Irvine, CA · +13 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.